Vestcor Inc’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
19,671
-4,442
-18% -$303K 0.04% 415
2026
Q1
$1.56M Sell
24,113
-9,399
-28% -$663K 0.04% 387
2025
Q4
$2.25M Sell
33,512
-9,299
-22% -$626K 0.06% 301
2025
Q3
$3.14M Sell
42,811
-1,802
-4% -$120K 0.09% 231
2025
Q2
$2.32M Buy
+44,613
New +$2.54M 0.07% 299
2025
Q1
– Sell
-9,831
Closed -$470K – 1209
2024
Q4
$470K Hold
9,831
– – 0.02% 701
2024
Q3
$563K Hold
9,831
– – 0.02% 652
2024
Q2
$515K Hold
9,831
– – 0.02% 649
2024
Q1
$400K Hold
9,831
– – 0.01% 727
2023
Q4
$363K Hold
9,831
– – 0.01% 772
2023
Q3
$376K Buy
+9,831
New +$403K 0.01% 734
2023
Q2
– Sell
-5,932
Closed -$227K – 1110
2023
Q1
$227K Hold
5,932
– – 0.01% 845
2022
Q4
$338K Buy
+5,932
New +$304K 0.01% 759

Other funds holding HALO

Vestcor Inc's HALO Position: Q2 2026 in Review

Vestcor Inc reduced its Halozyme (HALO) stake by 18% in Q2 2026, selling an estimated $303K and leaving 19,671 shares worth $1.54M. The position accounts for 0.04% of the portfolio, ranked #415.

Vestcor Inc first reported a position in HALO in Q4 2022 and has held it in 13 quarters since. The position peaked at $3.14M in Q3 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Vestcor Inc held 19,671 shares of Halozyme worth $1.54M as of Q2 2026.
  • Vestcor Inc sold 4,442 Halozyme shares in Q2 2026, an estimated $303K.
  • Halozyme made up 0.04% of Vestcor Inc's portfolio in Q2 2026, its #415 holding.
  • Vestcor Inc first reported a position in Halozyme in Q4 2022 and has held it in 13 quarters since.
  • Vestcor Inc's Halozyme position peaked at $3.14M in Q3 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.